Andrew Huberman· PhD
Blood biomarkers are relevant to Alzheimer's disease.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Blood biomarkers are relevant to Alzheimer's disease.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the punchline when it comes to alzheimer's disease is we get pretty darn good information from the blood we get the relevant genes we get all the vascular stuff we get all the metabolic stuff kind of mickey mouse on the inflammatory stuff kind of mickey mouse on what toxins to look for because truthfully we just don't know